The immediate-early gene Nur77, which encodes an orphan nuclear receptor, is rapidly induced by various stress stimuli, including tumor necrosis factor (TNF). Nur77 has been implicated in mediating apoptosis, particularly in T cells and tumor cells. We report here that Nur77 can play a role in antagonizing apoptosis in TNF signaling. Nur77 expression is strongly induced by TNF. Interestingly, unlike most antiapoptotic molecules, this induced expression of Nur77 is largely independent of NF-B. Ectopic expression of Nur77 can protect wild-type, TRAF2 ؊/؊ , and RelA ؊/؊ cells from apoptosis induced by TNF, whereas expression of a dominantnegative form of Nur77 (DN-Nur77) accelerates TNF-mediated cell death in the mutant cells. In mouse embryonic fibroblasts, Nur77 remains in the nucleus in response to TNF and is not translocated to the mitochondria, where it was reported to mediate apoptosis. Our results suggest that Nur77 is a survival effector protein in the context of TNF-mediated signaling.
T he protein Nur77, also known as TR3 or nerve growth factor-induced clone B (NGFI-B) (1-3), has been implicated as a mediator of thymocyte and T cell apoptosis (4, 5) . Originally identified as an immediate-early gene rapidly induced by serum and growth factors including NGF (2, 3), Nur77 is a member of the steroid hormone nuclear receptor superfamily and has no known ligands. It is composed of an N-terminal transactivation domain, a central-terminal DNA-binding domain, and a Cterminal ligand-binding domain (6) .
The Nur77 (NGFI-B) subfamily consists of three members: Nur77 (NGFI-B␣), Nurr1 (NGFI-B␤), and Nor1 (NGFI-B␥) (7, 8) . The DNA-binding domains of these proteins are Ͼ90% homologous, whereas the ligand-binding domains are intermediately conserved in this subfamily (9) . In contrast, the sequences of the transactivation domain are not well conserved. Although Nur77 is widely expressed in various tissues (10) (11) (12) (13) , Nurr1 is detected primarily in thymus, osteoblasts, liver, and pituitary gland (13) (14) (15) , and Nor1 is expressed at a high level in the pituitary gland but at low levels in thymus, kidney, heart, skeletal muscle, and adrenal glands (15) (16) (17) . Nur77 subfamily members have been shown to bind DNA as monomers, homodimers, or heterodimers with retinoid X receptor (18) . Nur77 is constitutively active when overexpressed, suggesting the possibility that Nur77 activity does not require ligand stimulation.
It has been reported that Nur77 is inducible by T cell receptor signals and that its expression is high during T cell receptormediated apoptosis (4, 5) . Inhibition of Nur77 function by a dominant-negative (DN) Nur77 blocks T cell receptor-mediated apoptosis in thymocytes as well as in the negative selection, whereas thymocytes from Nur77-expressing transgenic mice show massive apoptosis (19, 20) . However, Nur77 knockout mice do not exhibit any defect in thymocyte apoptosis (21) , suggesting a potential functional redundancy among Nur77 family members. Although it remains unclear how Nur77 functions to mediate apoptosis, a recent article (33) suggests that, in response to certain apoptotic stimuli, Nur77 is translocated from the nucleus to the mitochondria, where it induces cytochrome c release. In this scenario, the transactivation activity of Nur77 may not be required for its proapoptotic effect. However, it has also been shown that Akt͞PKB can phosphorylate Nur77, which inhibits the functions of Nur77 as a transcription factor (22) and as a mediator of apoptosis in T cells.
Although Nur77 is mainly implicated in promoting apoptosis, overexpression of Nur77 has been reported to prevent ceramideinduced cell death (23) , suggesting a functional versatility of this protein to regulate apoptosis. In this article, we identify Nur77 as a transcriptional target gene downstream of signals induced by tumor necrosis factor (TNF). Expression of Nur77 is critical for protecting cells from undergoing TNF-induced apoptosis and can inhibit cell death at the step of caspase-8 activation. TNF and its related death factor can induce both cell death and survival pathways, and deregulation of the balance between these opposing pathways could result in the accumulation of unwanted cells. Therefore, understanding the mechanisms of the cell fate decision on TNF stimulation bears important implications in critical health problems such as cancers and autoimmune diseases.
Methods
Microarray Analysis. Mouse embryonic fibroblasts (MEFs) derived from wild-type, RelA Ϫ/Ϫ , or TRAF2 Ϫ/Ϫ mice were treated with TNF (10 ng͞ml) for 2 h. Approximately 1 ϫ 10 8 treated MEFs and matching untreated MEFs were harvested from each type of mouse for hybridization probe synthesis. Polyadenylated RNA was prepared from total RNA in Oligotex-dT resin (Qiagen, Valencia, CA), and each mRNA sample was converted into fluorescence-labeled cDNA probes by using the microarray (GEM) probe labeling kit (Synteni, Fremont, CA). These probes were forwarded to Synteni for hybridization onto a microarray containing 9,863 mouse cDNA clones. For each hybridization, the probe pair consisted of wild-type MEF and either RelA Ϫ/Ϫ or TRAF2 Ϫ/Ϫ MEF; both were either treated or untreated with TNF. Hybridization was performed in duplicates to ensure data reliability. Differential expression values were displayed as ϩP1͞ P2, where P1 signal Ͼ P2 signal, or ϪP2͞P1, where P1 signal Ͻ P2 signal. Clones having a value of Ͼ2 (ϩ or Ϫ) were identified and the corresponding cDNA was subcloned for further investigations.
Northern Blot Analysis. Messenger RNA was extracted from wild-type, TRAF2 Ϫ/Ϫ , and RelA Ϫ/Ϫ fibroblast cell lines that were untreated or treated with TNF (10 ng͞ml) for 2, 6, or 24 h by using TRIzol reagent and the protocol supplied by the manufacturer (Invitrogen). Five micrograms of each RNA sample was electrophoresed through a 1% denaturing formaldehydeagarose gel, transferred to a nylon membrane (Hybond N membrane, Amersham Biosciences), and hybridized to cDNA fragments specific for Nur77 or GAPDH. The probes were labeled with radioactive isotopes by using a multiprime DNA labeling system according to the manufacturer's instructions (Amersham Biosciences).
Western Blot Analysis. The protein samples were fractionated by 10% SDS͞PAGE and blotted onto a nitrocellulose membrane. The Western blot was probed with a polyclonal antibody raised against a specific polypeptide, derived from Nur77, or with ␤-actin antibody, and developed by using the ECL system according to the manufacturer's instructions (Amersham Biosciences).
Death Assay by Transient Transfection. Cells were transfected with various expression vectors plus CMV-lacZ, which constitutively expresses ␤-galactosidase. After 24 h, transfected cells were treated with TNF (10 ng͞ml) to induce cell death. After a 24-h induction of cell death, cells were stained for ␤-galactosidase expression. Cells in each well of the six-well plate were washed once with 2 ml of PBS, fixed with 2% paraformaldehyde in 1 ml of PBS for 30 min at room temperature, washed twice with 2 ml of PBS each, and stained with 2 ml of X-Gal solution [PBS containing 2 mM MgCl 2 , 4 mM potassium ferricyanide, 4 mM potassium ferrocyanide, and 0.4 mg͞ml X-Gal (5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside)] at 37°C for 6 h. Bluestained cells are transfected cells, and elongated attached cells are viable cells. Five random high-power fields were examined under light microscope, and cell viability was calculated based on the number of the viable blue-stained cells over the number of total blue-stained cells. Transfection with Retrovirus Expression Vectors. pBabe-puro (24), an MuLV-based retroviral vector, was used to transduce the target gene. The day before transfection, the Phoenix packaging cell line was plated at 5 ϫ 10 6 cells per 10-cm plate. Cells were grown to 70-80% confluency and transfected with empty pBabe-puro, pBabe-Nur77, or pBabe-DN-Nur77 vectors by using the calcium-phosphate method. Viral supernatants for infection were collected 48 h after transfection and were then added to RelA Ϫ/Ϫ or TRAF2 Ϫ/Ϫ cells. The infected cells were grown for 24 h and then subjected to selection in the same medium containing puromycin (0.5 g͞ml).
Death Assay on MEF. Cells (1.2 ϫ 10 5 ) were plated onto six-well plates in DMEM supplemented with 10% FBS and 2-mercaptoethanol. After a 24-h incubation period, TNF (10 ng͞ml) alone or TNF in combination with various concentrations of cycloheximide (Sigma) as indicated were added to induce cell death. After 24 h of culture, cells were harvested, stained with propidium iodide (PharMingen), and analyzed by flow cytometry to determine cell viability.
Caspase Assays. Caspase-3 activity was analyzed by using the substrate Ac-DEVD-AMC (PharMingen) as described by Hughes et al. (25) . Active caspase-3 cleaves the substrate Ac-DEVD-AMC after the aspartic acid (D) residue and before the AMC group. The released AMC becomes fluorescent, and the fluorescence is quantified by a fluorometer. The caspase-8 assay was carried out similarly by using the substrate Ac-IETD-AFC (BD Biosciences CLONTECH).
Immunohistochemical and Fluorescence Analysis. Fluorescence analysis was performed as described (26) . To visualize cytochrome c, cells were fixed in 4% paraformaldehyde for 10 min, permeabilized with 0.5% Triton X-100 for 10 min, and incubated with antibody against cytochrome c (Sigma) for 2 h. This was followed by a 45-min incubation with a 1:1,000 dilution of FITCconjugated goat anti-mouse IgG (Sigma). Cells were examined under a Nikon microscope and photographed with computerbased image capture.
Results
Nur77 Is a Transcriptionally Regulated Target Gene Downstream of TNF Signals. Stimulation of various cells with TNF or related death factors can potentially activate both the cell-death pathway and the survival program. Although the death pathway induced by death factors has been well characterized, our understanding of the survival program remains at a primitive stage. Previously, we reported that TRAF2 deficiency, similar to the defect of NF-B, renders the cells hypersensitive to TNF-induced cell death. TRAF2 and NF-B, therefore, play key roles in mediating cell survival signals. Because cells normally resistant to TNF typically become susceptible to TNF-induced death in the presence of actinomycin D or cycloheximide, the survival signals seem to depend on de novo gene transcription and protein synthesis. Indeed, several candidate survival effector genes, including cIAP family proteins (27) , IEX-1L (28), A1͞Bfl-1 (29), cFLIP (30) , and A20 (31, 32) , have been identified to be TNFinducible. Interestingly, so far the induced expressions of these survival genes have all been shown to depend on the activation of NF-B.
In this study, we first used microarray analysis to compare the TNF-induced gene expression patterns of TRAF2-deficient and NF-B-deficient (RelA Ϫ/Ϫ ) MEFs with their wild-type counterparts. We were particularly interested in genes that were inducible by TNF in wild-type cells but showed reduced induction in cells lacking NF-B or TRAF2. One of these genes identified from the microarray analysis was Nur77. Indeed, Northern blot analysis confirmed that Nur77 was highly induced in wild-type cells after 2 h of TNF stimulation. Interestingly, the induced expression of Nur77 mRNA was impaired in TRAF2 Ϫ/Ϫ cells but only mildly defective in cells lacking RelA (Fig. 1A) . We next examined the expression of Nur77 protein in several wild-type, RelA Fig. 2A) . TRAF2 Ϫ/Ϫ control cell lines were generally resistant to TNF alone but were highly sensitive to TNF plus CHX. However, TRAF2 Ϫ/Ϫ cell lines expressing Nur77 were resistant to TNF with or without the presence of CHX (Fig. 2B) .
Inhibition of Nur77 by Using a DN Mutant Accelerates TNF-Induced Cell
Death. Nur77 knockouts do not exhibit an abnormal cell death phenotype, whereas a DN mutant of Nur77 (DN-Nur77) that is defective in its transactivation domain effectively blocks T cell receptor-induced apoptosis. We first investigated the effect of DN-Nur77 stable overexpression on TNF-induced cell death in wild-type cells. However, we found that there was no increase in TNF-induced death in cells overexpressing DN-Nur77 (Fig. 3A) . In contrast, overexpression of Nur77 in wild-type cells provided a survival advantage against the challenge of TNF plus cycloheximide (Fig. 3A) .
One possible reason for the failure of DN-Nur77 to sensitize wild-type cells to TNF-induced apoptosis is that there may be multiple survival pathways functioning simultaneously in NF-B and TRAF2-competent cells. Alternatively, the amount of Nur77 expression induced by TNF in wild-type cells may be too great to be neutralized by DN-Nur77. We therefore investigated the effect of DN-Nur77 overexpression in RelA (Fig. 3 B and C) . These results suggest that the cytoprotective activity of Nur77 is at least partly attributable to its role as a transcription factor. (Fig. 4C) . Thus, overexpression of Nur77 can antagonize the activation of caspase-8 and subsequently caspase-3 to protect the mutant cells that are normally susceptible to TNF killing. MEFs, Nur77 remained localized in the nucleus in response to TNF stimulation (Fig. 5) . In contrast, staining of cytochrome c revealed that its localization was contained in the cytosolic mitochondria in the remaining viable cells (Fig. 5) . Thus, unlike the setting where Nur77 promotes cell death in the mitochondria, the cytoprotective effect of Nur77 against TNF challenge is correlated with its localization to the nucleus. 
Discussion
Most of the studies on Nur77 have focused on its potential proapoptotic functions in T cells and tumor cells. Here, we described an observation that the induced expression of Nur77, an immediate-early responsive gene to stress, may play a role in protecting against TNF-induced cell death in MEFs. Interestingly, the induction of Nur77 expression is largely independent of RelA, a critical subunit of NF-B activity in MEFs. We cannot rule out the possibility that other NF-B subunits may be involved in the transcriptional regulation of Nur77. However, TNF-induced Nur77 expression was little or only mildly affected in cells lacking NEMO, a critical modulator of IB kinase complex upstream of NF-B subunits (C.M., unpublished observation). Taken together, at least a significant portion of Nur77 expression is controlled by NF-B-independent pathways. TRAF2, a key molecule in mediating TNF-induced c-Jun N-terminal kinase activation, potentially plays a role in the activation of NF-B-independent antiapoptotic pathways and the induction of Nur77. It may be worth noting that roughly half of TRAF2 Ϫ/Ϫ mice are embryonic lethal, because of fetal liver degeneration, whereas the other half were born alive but developed severe wasting syndrome (34) . The molecular mechanism for this bipartite phenotype remains unclear, and further studies are required to determine whether this phenotype variation is correlated with the Nur77 expression patterns in different TRAF2 Ϫ/Ϫ cell lines. Alternatively, the variable levels of Nur77 induction by TNF may simply be due to clonal variations resulting from the process of spontaneous MEF transformation.
In response to TNF ligation, TNFR1 forms a death-inducing signaling complex that is similar to that assembled by Fas (CD95), including the recruitment of FADD and the activation of caspase-8 (35) . Caspase-8 can activate downstream caspases such as caspase-3 directly, or it can activate BID by truncation, Fluorometric caspase-3 enzymatic activity was measured by using a specific substrate Ac-DEVD-AMC as described in Methods. (C) Caspase-8 enzymatic activity was measured by using the substrate Ac-IETD-AFC as described in Methods. which then initiates a mitochondrial apoptotic cascade that results in the activation of caspase-9 and caspase-3. We showed that Nur77 protects cells from TNF-induced death by blocking caspase-3 as well as caspase-8 activities, suggesting that the activity of Nur77 likely affects the cell death as early as caspase-8 activation. Because Nur77 stays in the nucleus after TNF stimulation, it is possible that some of its transcriptional target gene products play a role in modulating death-inducing signaling complex formation or directly counteracting caspase-8. Further studies will be required to address this issue.
Two separate mechanisms have been proposed to account for the proapoptotic activities of Nur77. One theory suggests that the proapoptotic effect of Nur77 depends on its DNA-binding and transactivation abilities (5, 19) . The second potential mechanism suggests that the translocation of Nur77 to the mitochondria is essential for its killer effect (33) . Although it remains debatable how Nur77 functions to regulate apoptosis, our results suggest that the antiapoptotic effect of Nur77 arises from its function in the nucleus. The exact nature of the role of Nur77 in the nucleus, be it transactivating or repressing, remains to be investigated.
Consistent with our finding of a potential antiapoptotic role for Nur77, expression of Nur77 is induced rapidly by a variety of growth stimuli, including growth factors and phorbol esters. Overexpression of Nur77 in certain human lung cancer cells is correlated with their resistance to retinoic acid treatment, which inhibits cell growth, and may contribute to cell proliferation and neoplastic transformation (36) . Interestingly, Nor-1, a Nur77 family member, has been reported to be involved in the t (9, 22) chromosomal translocation in extraskeletal myxoid chondrosarcoma (37) . The resulting fusion protein, EWS͞TEC (Nor-1 is also called TEC), is potentially oncogenic, and it is much more active than the native receptor in transactivating target promoters. In addition, we have observed that some MEF clones overexpressing Nur77, when cultured on the soft agar, showed anchorage-independent growth and colony formation (S.S. and N.S., unpublished observation), suggesting that Nur77 may have oncogenic potential in certain cellular context.
Taken together, our results suggest that Nur77 functions as an antiapoptotic factor in the context of TNF signaling. As the experimental system we used here depends on protein overexpression, the physiological significance of Nur77 in death receptor-mediated apoptosis regulation requires further investigation. The antiapoptotic function of Nur77 may depend on its effect on transcriptional regulation, thereby relaying the cytoprotective effect to specific downstream targets. Because overexpression or abnormal activation of cell survival factors are implicated in oncogenesis, further studies of Nur77 signaling may provide useful insights into the molecular mechanisms of death receptor signal transduction and tumor biology.
